PACB
Pacific Biosciences·NASDAQ
--
--(--)
--
--(--)
0.91 / 10
Underperform
The equity presents weak fundamental picture (0.9/10). Strengths include Net profit attributable to parent company shareholders / Net profit (%) and Revenue-MV, despite concerns regarding Net income-Revenue and Current assets turnover ratio. This merits selective consideration.
Analysis Checks(2/10)
Revenue-MV
Value-0.47
Score2/3
Weight-23.71%
1M Return3.00%
Value-0.47
Score2/3
Weight-23.71%
1M Return3.00%
Total operating revenue (YoY growth rate %)
Value0.50
Score1/3
Weight14.85%
1M Return-2.56%
Value0.50
Score1/3
Weight14.85%
1M Return-2.56%
Net income-Revenue
Value-0.17
Score1/3
Weight4.84%
1M Return-0.69%
Value-0.17
Score1/3
Weight4.84%
1M Return-0.69%
Current assets turnover ratio
Value0.26
Score0/3
Weight33.00%
1M Return-7.31%
Value0.26
Score0/3
Weight33.00%
1M Return-7.31%
Asset-MV
Value-0.50
Score0/3
Weight14.24%
1M Return-6.43%
Value-0.50
Score0/3
Weight14.24%
1M Return-6.43%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight10.84%
1M Return-1.63%
Value100.00
Score2/3
Weight10.84%
1M Return-1.63%
Net cash flow from operating activities / Operating revenue (%)
Value-79.87
Score1/3
Weight11.82%
1M Return-2.03%
Value-79.87
Score1/3
Weight11.82%
1M Return-2.03%
Net profit margin (%)
Value-438.63
Score1/3
Weight9.43%
1M Return-1.60%
Value-438.63
Score1/3
Weight9.43%
1M Return-1.60%
EBIT / Total operating revenue (%)
Value-434.01
Score1/3
Weight13.61%
1M Return-2.44%
Value-434.01
Score1/3
Weight13.61%
1M Return-2.44%
Net profit / Total operating revenue (%)
Value-438.63
Score1/3
Weight11.08%
1M Return-1.90%
Value-438.63
Score1/3
Weight11.08%
1M Return-1.90%
Revenue-MV
Value-0.47
Score2/3
Weight-23.71%
1M Return3.00%
Value-0.47
Score2/3
Weight-23.71%
1M Return3.00%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight10.84%
1M Return-1.63%
Value100.00
Score2/3
Weight10.84%
1M Return-1.63%
Total operating revenue (YoY growth rate %)
Value0.50
Score1/3
Weight14.85%
1M Return-2.56%
Value0.50
Score1/3
Weight14.85%
1M Return-2.56%
Net cash flow from operating activities / Operating revenue (%)
Value-79.87
Score1/3
Weight11.82%
1M Return-2.03%
Value-79.87
Score1/3
Weight11.82%
1M Return-2.03%
Net income-Revenue
Value-0.17
Score1/3
Weight4.84%
1M Return-0.69%
Value-0.17
Score1/3
Weight4.84%
1M Return-0.69%
Net profit margin (%)
Value-438.63
Score1/3
Weight9.43%
1M Return-1.60%
Value-438.63
Score1/3
Weight9.43%
1M Return-1.60%
Current assets turnover ratio
Value0.26
Score0/3
Weight33.00%
1M Return-7.31%
Value0.26
Score0/3
Weight33.00%
1M Return-7.31%
EBIT / Total operating revenue (%)
Value-434.01
Score1/3
Weight13.61%
1M Return-2.44%
Value-434.01
Score1/3
Weight13.61%
1M Return-2.44%
Asset-MV
Value-0.50
Score0/3
Weight14.24%
1M Return-6.43%
Value-0.50
Score0/3
Weight14.24%
1M Return-6.43%
Net profit / Total operating revenue (%)
Value-438.63
Score1/3
Weight11.08%
1M Return-1.90%
Value-438.63
Score1/3
Weight11.08%
1M Return-1.90%
Is PACB undervalued or overvalued?
- PACB scores 0.91/10 on fundamentals and holds a Premium valuation at present. Backed by its -186.48% ROE, -325.80% net margin, -1.04 P/E ratio, 15.23 P/B ratio, and -14.38% earnings growth, these metrics solidify its Underperform investment rating.
